FIELD: biotechnology.
SUBSTANCE: invention relates to racemic 2,17β-disulfomoyloxy-3-methoxy-8α-extra-1,3,5(10)-triene inhibiting tumour cell proliferation of breast cancer MCF-7.
EFFECT: improvement of properties.
1 ex
| Title | Year | Author | Number |
|---|---|---|---|
| RACEMIC 2,17ALFABETA-DISULFAMOYLOXY-3-METHOXY-D-HOMO-8ALPHA-ESTRA-1,3,5 (10)-TRIENE AS MSF-7 TUMOR CELLS PROLIFERATION INHIBITOR | 2016 |
|
RU2629186C1 |
| 7β-METHYL-3,17αβ-DISULFAMOYLOXY-D-HOMO-6-OXA-ESTRA-1,3,5(10), 8,14-PENTAEN AS BREAST CANCER MCF-7 CELLS GROWTH INHIBITOR | 2016 |
|
RU2619457C1 |
| 2-ETHYL-6-OXAESTRA-1,3,5(10),8,14-PENTENES SULFAMATES AS MCF-7 TUMOUR CELLS PROLIFERATION INHIBITORS | 2016 |
|
RU2620084C1 |
| 3-O-SULFAMOILOXY-6-OXA-7Β-METHYL-D-HOMO-8Α-ESTRA-1,3,5(10)-TRIEN-17Α-ONE APPLICATION FOR THE BREAST CANCER TREATMENT, INCLUDING THE TRIPLE NEGATIVE FORM, AND ITS PRODUCTION METHOD | 2018 |
|
RU2679625C1 |
| USE OF 3-O-SULFAMOYLOXY-7Β-METHYL-D-HOMO-6-OXAESTRA-1,3,5(10),8(9)-TETRAEN-17A-ONE FOR THE TREATMENT OF BREAST CANCER, INCLUDING A TRIPLE NEGATIVE FORM | 2018 |
|
RU2678845C1 |
| 3-METHOXY-2-FLUORO-18-ETHYL-8α-GONA-1,3,5( 10 )-TRIENES, HAVING OSTEOPROTECTOR AND HYPOCHOLESTEREMIC ACTIVITY | 2009 |
|
RU2418000C1 |
| 16α,17α-CYCLOHEXA-17β-2'-HYDROXYETHYL)-13β-METHYLGONA-1,3,5(10)-TRIEN-3-OL AND PREPARATION METHOD THEREOF | 2015 |
|
RU2601423C1 |
| RACEMIC 3-HYDROXY-16-METHYL-2-FLUORO-13a-ESTRA-1,3,5(10),8(9),15-PENTAEN-17-ONE AS MEANS OF HORMONE REPLACEMENT THERAPY AND METHOD OF OBTAINING THEREOF | 2013 |
|
RU2526264C1 |
| BENZOPIPERIDINE DERIVATIVES, BICYCLIC COMPOUNDS AND PHARMACEUTICAL COMPOSITION BASED ON SAID | 1992 |
|
RU2142945C1 |
| [N'-(ISO)QUINOLYLMETHYLENE]HYDRAZIDES OF 3-METHOXY-13,17-SECOESTRA-1,3,5(10)-TRIEN-17-OIC ACID | 2023 |
|
RU2801166C1 |
